Journey Strategic Wealth LLC Boosts Stock Position in Procter & Gamble Company (The) (NYSE:PG)

Journey Strategic Wealth LLC boosted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 55.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 29,098 shares of the company's stock after purchasing an additional 10,344 shares during the period. Journey Strategic Wealth LLC's holdings in Procter & Gamble were worth $4,959,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC increased its stake in Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after acquiring an additional 13,617 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in Procter & Gamble by 493.6% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 341,750 shares of the company's stock valued at $57,294,000 after acquiring an additional 284,174 shares during the period. Zions Bancorporation N.A. lifted its holdings in shares of Procter & Gamble by 40.9% in the 4th quarter. Zions Bancorporation N.A. now owns 7,006 shares of the company's stock worth $1,175,000 after buying an additional 2,035 shares during the period. PKS Advisory Services LLC purchased a new stake in shares of Procter & Gamble in the 4th quarter worth $294,000. Finally, Murphy & Mullick Capital Management Corp purchased a new stake in shares of Procter & Gamble in the 4th quarter worth $314,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Trading Down 0.3%

Shares of PG stock traded down $0.53 on Friday, hitting $158.28. The stock had a trading volume of 5,799,883 shares, compared to its average volume of 9,070,670. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50. The firm has a market capitalization of $371.10 billion, a P/E ratio of 25.12, a P/E/G ratio of 4.52 and a beta of 0.40. Procter & Gamble Company has a 1 year low of $151.90 and a 1 year high of $180.43. The company's 50 day moving average price is $161.02 and its 200-day moving average price is $164.22.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Thursday, April 24th. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The firm had revenue of $19.78 billion during the quarter, compared to analysts' expectations of $20.42 billion. During the same period in the previous year, the firm posted $1.52 EPS. Procter & Gamble's revenue for the quarter was down 2.1% on a year-over-year basis. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a dividend of $1.0568 per share. The ex-dividend date is Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.67%. Procter & Gamble's payout ratio is 67.14%.

Wall Street Analysts Forecast Growth

PG has been the subject of a number of analyst reports. Evercore ISI restated an "in-line" rating and set a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Morgan Stanley set a $180.00 target price on Procter & Gamble and gave the stock an "overweight" rating in a report on Friday, April 25th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a report on Friday. Erste Group Bank downgraded Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Citigroup lowered their price target on Procter & Gamble from $200.00 to $181.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Nine investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $176.12.

Insider Buying and Selling at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total transaction of $1,669,208.40. Following the completion of the transaction, the insider directly owned 25,182 shares of the company's stock, valued at approximately $3,995,627.94. This represents a 29.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the transaction, the chief executive officer directly owned 51,965 shares of the company's stock, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.